These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1812743)

  • 1. Substrate cleavage by HIV-1 proteinase.
    Jupp RA; Richards AD; Phylip LH; Kay J; Konvalinka J; Strop P; Kostka V; Scarborough PE; Farmerie WG; Dunn BM
    Adv Exp Med Biol; 1991; 306():461-7. PubMed ID: 1812743
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.
    Darke PL; Kohl NE; Hanobik MG; Leu CT; Vacca JP; Guare JP; Heimbach JC; Dixon RA
    Adv Exp Med Biol; 1991; 306():483-7. PubMed ID: 1812746
    [No Abstract]   [Full Text] [Related]  

  • 3. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
    Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
    Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
    FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-engineered proteinase of myeloblastosis associated virus, an enzyme of high activity and HIV-1 proteinase-like specificity.
    Strop P; Horejsí M; Konvalinka J; Skrabana R; Velek J; Bláha I; Cerná V; Pichová I; Pavlícková L; Andreánsky M
    Adv Exp Med Biol; 1991; 306():515-8. PubMed ID: 1812751
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
    Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
    J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.
    Tözsér J; Yin FH; Cheng YS; Bagossi P; Weber IT; Harrison RW; Oroszlan S
    Eur J Biochem; 1997 Feb; 244(1):235-41. PubMed ID: 9063469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
    Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitive, hydrosoluble, macromolecular fluorogenic substrates for human immunodeficiency virus 1 proteinase.
    Anjuère F; Monsigny M; Lelièvre Y; Mayer R
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):869-73. PubMed ID: 8489513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
    Phylip LH; Richards AD; Kay J; Kovalinka J; Strop P; Blaha I; Velek J; Kostka V; Ritchie AJ; Broadhurst AV
    Biochem Biophys Res Commun; 1990 Aug; 171(1):439-44. PubMed ID: 2203349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 RT enhances the activity of a tethered dimer of HIV-1 proteinase.
    Goobar-Larsson L; Larsson PT; Debouck C; Towler EM
    Biochem Biophys Res Commun; 1996 Mar; 220(1):203-7. PubMed ID: 8602845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity study of recombinant Rhizopus chinensis aspartic proteinase.
    Lowther WT; Chen Z; Lin XL; Tang J; Dunn BM
    Adv Exp Med Biol; 1991; 306():275-9. PubMed ID: 1812717
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.
    Fehér A; Weber IT; Bagossi P; Boross P; Mahalingam B; Louis JM; Copeland TD; Torshin IY; Harrison RW; Tözsér J
    Eur J Biochem; 2002 Aug; 269(16):4114-20. PubMed ID: 12180988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
    Louis JM; McDonald RA; Nashed NT; Wondrak EM; Jerina DM; Oroszlan S; Mora PT
    Eur J Biochem; 1991 Jul; 199(2):361-9. PubMed ID: 2070793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
    Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
    Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of genetically linked homo- and hetero-dimers of HIV proteinase.
    Kräusslich HG; Traenckner AM; Rippmann F
    Adv Exp Med Biol; 1991; 306():417-28. PubMed ID: 1812738
    [No Abstract]   [Full Text] [Related]  

  • 18. Cloning, isolation, expression and mutagenesis studies on the human immuno-deficiency virus type 1 (HIV-1) protease.
    Garner JC; Shoolingin-Jordan PM
    Biochem Soc Trans; 1998 Aug; 26(3):S287. PubMed ID: 9766006
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
    Tözsér J; Bláha I; Copeland TD; Wondrak EM; Oroszlan S
    FEBS Lett; 1991 Apr; 281(1-2):77-80. PubMed ID: 2015912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.
    Mildner AM; Rothrock DJ; Leone JW; Bannow CA; Lull JM; Reardon IM; Sarcich JL; Howe WJ; Tomich CS; Smith CW
    Biochemistry; 1994 Aug; 33(32):9405-13. PubMed ID: 8068616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.